Evaluation of Narcolepsy using Dreem 3S Sleep Monitor

Study Description

Evaluating the Effectiveness of the Dreem 3S Sleep Monitor for Diagnosing Narcolepsy

Study Details

Registry ID:

NCT06531876

Conditions:

Narcolepsy Type 1, Hypersomnia, Sleep Disorder

Phase:

Target Enrollment:

78 participants

Start Date:

July 1, 2024

Age Range:

18–999 years

Healthy Volunteers:

No

Study Locations (4 sites)

• Sleep Insights Medical Associates PLLC
  Rochester, New YorkUnited States, United States
• Intrepid Research
  Cincinnati, OhioUnited States, United States
• Kaiser Permanente Fontana Medical Center
  Fontana, CaliforniaUnited States, United States
• Stanford University
  Redwood City, CaliforniaUnited States, United States

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →